within Pharmacolibrary.Drugs.N_NervousSystem.N02B_OtherAnalgesicsAndAntipyretics.N02BB01_Phenazone;

model Phenazone
  extends Pharmacolibrary.Drugs.ATC.N.N02BB01;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>N02BB01</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Phenazone (also known as antipyrine) is a non-opioid analgesic and antipyretic formerly used for the relief of pain and fever. It is a pyrazolone derivative. Its use today is rare in many countries, having been largely replaced by safer and more effective agents, though it remains a classic model drug in pharmacokinetics studies due to well-established metabolic pathways.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult volunteers (mixed sex, typical age 20-40 years) after a single oral dose.</p><h4>References</h4><ol><li><p>Shimizu, H, et al., &amp; Kondo, K (2021). Evaluation of Pharmacokinetics, Safety, and Drug-Drug Interactions of an Oral Suspension of Edaravone in Healthy Adults. <i>Clinical pharmacology in drug development</i> 10(10) 1174–1187. DOI:<a href=\"https://doi.org/10.1002/cpdd.925\">10.1002/cpdd.925</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/33704925/\">https://pubmed.ncbi.nlm.nih.gov/33704925</a></p></li><li><p>Bireley, JD, &amp; Morren, JA (2023). CNM-Au8: an experimental agent for the treatment of amyotrophic lateral sclerosis (ALS). <i>Expert opinion on investigational drugs</i> 32(8) 677–683. DOI:<a href=\"https://doi.org/10.1080/13543784.2023.2252738\">10.1080/13543784.2023.2252738</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/37642362/\">https://pubmed.ncbi.nlm.nih.gov/37642362</a></p></li><li><p>Klotz, U (2007). Antiarrhythmics: elimination and dosage considerations in hepatic impairment. <i>Clinical pharmacokinetics</i> 46(12) 985–996. DOI:<a href=\"https://doi.org/10.2165/00003088-200746120-00002\">10.2165/00003088-200746120-00002</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/18027986/\">https://pubmed.ncbi.nlm.nih.gov/18027986</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial generated model</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Phenazone;
